Malaria (plasmodium falciparum)
Clinical trials for Malaria (plasmodium falciparum) explained in plain language.
Never miss a new study
Get alerted when new Malaria (plasmodium falciparum) trials appear
Sign up with your email to follow new studies for Malaria (plasmodium falciparum), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Liver-Stage malaria vaccine shield mothers and babies?
Vaccine Recruiting nowThis phase 2 trial tests a new malaria vaccine (PfSPZ-LARC2) designed to stop the malaria parasite in the liver before it can cause illness. The study involves 300 healthy women of childbearing age in Mali who plan to become pregnant. Participants receive three doses of the vacci…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase 2 • Sponsor: Sanaria Inc. • Aim: Vaccine
Last updated Jul 25, 2026 00:00 UTC
-
New malaria vaccine shows promise in african trial
Vaccine Recruiting nowThis study tests a new malaria vaccine in 180 healthy adults aged 18-50 in Burkina Faso. The vaccine uses weakened malaria parasites that stop growing in the liver, so they cannot cause blood-stage infection. Participants receive either one or two doses of the vaccine or a placeb…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase 2 • Sponsor: Sanaria Inc. • Aim: Vaccine
Last updated Jun 27, 2026 13:01 UTC
-
Cancer drug could supercharge malaria treatment and beat resistance
Disease control Recruiting nowThis study tests whether adding imatinib, a drug currently used for cancer, to the standard malaria treatment (artemether + lumefantrine) can clear the malaria parasite faster and fight drug resistance. About 1,100 adults with mild to moderate malaria will receive either the stan…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase 2 • Sponsor: Victoria Biomedical Research Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC